135 related articles for article (PubMed ID: 6459270)
1. [Acceptability of medroxyprogesterone acetate in rural areas of Mexico].
Velasco Murillo V; Cervantes Bustamante A; Correu Azcona S; García López E
Ginecol Obstet Mex; 1981 Mar; 49(293):153-61. PubMed ID: 6459270
[TBL] [Abstract][Full Text] [Related]
2. [Parenteral contraceptive drugs: depot progestins].
Rabe T; Runnebaum B
Wien Med Wochenschr; 1987 Nov; 137(20-21):474-9. PubMed ID: 2967589
[TBL] [Abstract][Full Text] [Related]
3. [Acceptability of medroxyprogesterone acetate among medical and paramedical personnel in family planning].
Cervantes A; Velasco Murillo V; Campos Cordero J; Correu Azcona S
Ginecol Obstet Mex; 1982 Apr; 50(300):85-8. PubMed ID: 6222944
[TBL] [Abstract][Full Text] [Related]
4. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of injectable contraceptives in Mexican women].
Garza-Flores J; Rodríguez V; Cravioto MC; del Real Mora O; Anderson J; Landeros J; Díaz Sánchez V; Lichtenberg R; Pérez-Palacios G
Bol Oficina Sanit Panam; 1985 Feb; 98(2):181-6. PubMed ID: 3156612
[No Abstract] [Full Text] [Related]
6. [Prolonged use of medroxyprogesterone acetate for contraception].
Pena Delgado J; Aleman Herrera M; Baez Reyes A
Sem Med Mex; 1981 Jun; 98(11):331-50. PubMed ID: 12279435
[TBL] [Abstract][Full Text] [Related]
7. [Use and effectiveness of norethisterone enanthate for family planning in a rural area].
Velasco Murillo V; Ortiz López J; García López E; Correu Azcona S
Ginecol Obstet Mex; 1983 Jun; 51(314):163-7. PubMed ID: 6681299
[TBL] [Abstract][Full Text] [Related]
8. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
9. [Injectable contraception using depot progestagens].
Velasco Murillo V; Correu Azcona S
Ginecol Obstet Mex; 1983 Jul; 51(315):191-7. PubMed ID: 6242048
[TBL] [Abstract][Full Text] [Related]
10. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
Polaneczky M; Guarnaccia M; Alon J; Wiley J
Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
[TBL] [Abstract][Full Text] [Related]
11. Contraceptives and cancer--looking for the evidence.
Cent Afr J Med; 1992 Feb; 38(2):88-9. PubMed ID: 1387044
[No Abstract] [Full Text] [Related]
12. [20 questions aporopos of trimestrial injection of depot contraceptives].
Revaz C
Rev Med Suisse Romande; 1975 Sep; 95(9):661-71. PubMed ID: 1215719
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
Sobande AA; Al-Bar HM; Archibong EI; Sadek AA
Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816
[TBL] [Abstract][Full Text] [Related]
14. [Medroxyprogesterone acetate. Biochemical and clinical aspects].
Ayala AR; Almazań M
Ginecol Obstet Mex; 1982 Sep; 50(305):253-9. PubMed ID: 6226570
[No Abstract] [Full Text] [Related]
15. Use of depot medroxyprogesterone acetate contraception in adolescents.
Davis AJ
J Reprod Med; 1996 May; 41(5 Suppl):407-13. PubMed ID: 8725703
[TBL] [Abstract][Full Text] [Related]
16. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
London RS
J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
[TBL] [Abstract][Full Text] [Related]
17. [Depot medroxyprogesterone acetate: clinical and metabolic effects (lipids, glucose, hemostasis)].
Hyjazi Y; Maes E; Hurlet A; Masure R; Vekemans M
J Gynecol Obstet Biol Reprod (Paris); 1985; 14(1):93-103. PubMed ID: 3159786
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives: Pt. 2.
Family Planning Association of New South Wales
Fam Plann Inf Serv; 1978; 1(2):1-36. PubMed ID: 12338652
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives hold top position as leading choice for women.
Contracept Technol Update; 1997 Nov; 18(11):133-6. PubMed ID: 12292767
[TBL] [Abstract][Full Text] [Related]
20. [Real and false risks of injectable hormonal contraception].
Revaz C
Gynakol Rundsch; 1984; 24 Suppl 1():20-5. PubMed ID: 6240435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
